Timothy P Hofer, MD, MSc
Division of General Medicine, Internal Medicine
2800 Plymouth Road
Ann Arbor, MI 48109-2800
Manage Your Profile
About
I am currently a Professor of Medicine at the University of Michigan Medical School and the Associate Director for Analytic and Information Resources at the VA Center for Practice Management and Outcomes Research in Ann Arbor as well as a member of the UM Institute for Healthcare Policy and Innovation.
I work on measuring and improving quality of care in the complex patient. I am interested in the methodological and practical issues in measuring and profiling quality of care and how the ability to measure quality may affect popular policy initiatives to identify and reduce medical errors or set up pay for performance systems. My projects have focused on the adequacy of risk adjustment, social and economic factors predicting utilization, as well as the patient, provider and organizational influences on performance measurement and indicators. I am a core faculty member in the National Clinical Scholars Program at the University of Michigan (formerly the Robert Wood Johnson Clinical Scholars program) where I teach advanced analytic methods and I spend a significant amount of time on research mentoring and teaching research trainees.
Links
Academic/Research Home Page Google Scholar Reference Page National Library of Medicine Bibliography Institute for Health Policy and Innovation
Qualifications
-
Internal Medicine ResidencyUCSF, Medicine, San Francisco, USA
1986 - 1989
Residency
-
MDUniversity of California, School of Medicine, San Francisco, CA, United States
1981 - 1985
Center Memberships
-
Center MemberGlobal REACH
-
Center MemberCaswell Diabetes Institute
-
Center MemberCenter for Global Health Equity
-
Center MemberInstitute for Healthcare Policy and Innovation
Research Overview
Reducing overuse through deintensification of medical services
Quality Measurement and monitoring in the complex patient
Organizational effects on the quality of Cancer Care and decision-making about treatment
Physician Implicit Review in measuring quality of care
Multilevel organizational structures
Quality improvement in care for diabetes and other common chronic diseases
See Academic/Research Home page (link on left menu bar) for details of prior work in these areas
Recent Publications
-
Lilford RJ, Evison F, Reeves K, Skrybant M, Chilton PJ, Hofer TP, Watson SI. BMJ Open, 2026 Nov 1; 16 (11):Journal ArticleLong-term outcomes of ultrasound-detected hepatic steatosis in primary care: a record linkage study
DOI:10.1136/bmjopen-2026-124118 -
Hawley ST, Kidwell KM, Jagsi R, Barber AK, Wills R, Chow SL, Kour O, Segovia D, Abrahamse P, Resnicow K, Zikmund-Fisher BJ, Hofer TP, Neuman HB. Jnci Cancer Spectrum, 2026 Oct 1; 10 (5):Journal ArticleEvaluating a shared decision engagement system in the National Cancer Institute Community Oncology Research Program: a multi-level randomized controlled trial
DOI:10.1093/jncics/pkag100 PMID: 42804742 -
Saffar D, Rose L, Gao Y, Hofer T, Kerr E, Saini S, Adams M. Journal of General Internal Medicine, 2026 Jun 7;Journal ArticleTrends in outpatient specialty care referrals and specialty clinic wait times in the Veterans Affairs Health System Before and After VA Community Care Expansion
-
Kurian AW, Abrahamse P, Furgal A, Veenstra CM, Courser RR, Hofer TP, Hodan R, Caswell-Jin JL, Gomez SL, Ward KC, Hamilton AS, Liu L, An LC, Katz SJ. JCO precision oncology, 2026 Jun 3; 10 (6): e2600041Journal ArticleCommunication With Clinicians and Relatives About Cascade Genetic Testing in Cancer Patients With Germline Pathogenic Variants.
DOI:10.1200/po-26-00041 PMID: PMC13314380 -
Hofer TP. BMJ quality & safety, 2026 May 4; 35 (7): 474 - 486.Journal ArticleGrand rounds in methodology: four key things to know about the reliability of measurement.
DOI:10.1136/bmjqs-2025-018924 PMID: 42082361 -
Strohbehn GW, Tokaz MC, Shin DS, Jalal S, Tavalire HF, Gyori DJ, Moeller JA, Bazzell BG, Kelley MJ, Fendrick AM, Elliott DA, Ramnath N, Hofer TP, Bryant AK. JCO oncology practice, 2026 Jun 18; OP2501241Journal ArticleMaintenance Pemetrexed/Pembrolizumab Versus Pembrolizumab in Non-Small Cell Lung Cancer: A Propensity Score-Weighted Analysis.
DOI:10.1200/op-25-01241 PMID: 42314089 -
Veenstra CM, Abrahamse P, Ward K, Hamilton A, Hofer T, Katz SJ, Kurian A. 2026 May 28;Proceeding / Abstract / PosterIntensity of chemotherapy regimens for patients with Lynch syndrome and colorectal cancer
-
Katz SJ, Hofer TP, Abrahamse P, Courser RR, Hodan R, Tocco RS, Rios-Ventura S, Ward KC, Hamilton AS, Frey MK, An LC, Kurian AW. Journal of Clinical Oncology, 2026 May 1; 44 (13): 1216 - 1224.Journal ArticleResults From the Genetic Information and Family Testing Study: A Cluster-Randomized Trial
DOI:10.1200/JCO-25-02196 PMID: 41875376